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Autism Spectrum Disorder Fact Sheet 
 
 
What is autism spectrum disorder? 
Autism spectrum disorder (ASD) refers to a group of complex neurodevelopment disorders characterized by repetitive 
and characteristic patterns of behavior and difficulties with social communication and interaction. The symptoms are 
present from early childhood and affect daily functioning. 
The term “spectrum” refers to the wide range of symptoms, skills, and levels of disability in functioning that can occur 
in people with ASD. Some children and adults with ASD are fully able to perform all activities of daily living while 
others require substantial support to perform basic activities. The Diagnostic and Statistical Manual of Mental 
Disorders (DSM-5, published in 2013) includes Asperger syndrome, childhood disintegrative disorder, and pervasive 
developmental disorders not otherwise specified (PDD-NOS) as part of ASD rather than as separate disorders. A 
diagnosis of ASD includes an assessment of intellectual disability and language impairment. 
ASD occurs in every racial and ethnic group, and across all socioeconomic levels. However, boys are significantly 
more likely to develop ASD than girls. The latest analysis from the Centers for Disease Control and Prevention 
estimates that 1 in 68 children has ASD. 
What are some common signs of ASD? 
Even as infants, children with ASD may seem different, especially when compared to other children their own age. 
They may become overly focused on certain objects, rarely make eye contact, and fail to engage in typical babbling 
with their parents. In other cases, children may develop normally until the second or even third year of life, but then 
start to withdraw and become indifferent to social engagement. 
The severity of ASD can vary greatly and is based on the degree to which social communication, insistence of 
sameness of activities and surroundings, and repetitive patterns of behavior affect the daily functioning of the 
individual. 
Social impairment and communication difficulties 
Many people with ASD find social interactions difficult. The mutual give-and-take nature of typical communication 
and interaction is often particularly challenging. Children with ASD may fail to respond to their names, avoid eye 
contact with other people, and only interact with others to achieve specific goals. Often children with ASD do not 
understand how to play or engage with other children and may prefer to be alone. People with ASD may find it 
difficult to understand other people’s feelings or talk about their own feelings. 
People with ASD may have very different verbal abilities ranging from no speech at all to speech that is fluent, but 
awkward and inappropriate. Some children with ASD may have delayed speech and language skills, may repeat 
phrases, and give unrelated answers to questions. In addition, people with ASD can have a hard time using and 
understanding non-verbal cues such as gestures, body language, or tone of voice. For example, young children with 
ASD might not understand what it means to wave goodbye. People with ASD may also speak in flat, robot-like or a 
sing-song voice about a narrow range of favorite topics, with little regard for the interests of the person to whom they 
are speaking. 
Repetitive and characteristic behaviors 
Many children with ASD engage in repetitive movements or unusual behaviors such as flapping their arms, rocking 
from side to side, or twirling. They may become preoccupied with parts of objects like the wheels on a toy truck. 
Children may also become obsessively interested in a particular topic such as airplanes or memorizing train schedules. 
Many people with ASD seem to thrive so much on routine that changes to the daily patterns of life — like an 
unexpected stop on the way home from school — can be very challenging. Some children may even get angry or have 
emotional outbursts, especially when placed in a new or overly stimulating environment. 
 
 
What disorders are related to ASD? 
Certain known genetic disorders are associated with an increased risk for autism, including Fragile X syndrome (which 
causes intellectual disability) and tuberous sclerosis (which causes benign tumors to grow in the brain and other vital 
organs) — each of which results from a mutation in a single, but different, gene. Recently, researchers have discovered 
other genetic mutations in children diagnosed with autism, including some that have not yet been designated as named 
syndromes. While each of these disorders is rare, in aggregate, they may account for 20 percent or more of all autism 
cases. 
People with ASD also have a higher than average risk of having epilepsy. Children whose language skills regress early 
in life — before age 3 — appear to have a risk of developing epilepsy or seizure-like brain activity. About 20 to 30 
percent of children with ASD develop epilepsy by the time they reach adulthood. Additionally, people with both ASD 
and intellectual disability have the greatest risk of developing seizure disorder. 
How is ASD diagnosed? 
ASD symptoms can vary greatly from person to person depending on the severity of the disorder. Symptoms may even 
go unrecognized for young children who have mild ASD or less debilitating handicaps. Very early indicators that 
require evaluation by an expert include: 
• no babbling or pointing by age 1 
• no single words by age 16 months or two-word phrases by age 2 
• no response to name 
• loss of language or social skills previously acquired 
• poor eye contact 
• excessive lining up of toys or objects 
• no smiling or social responsiveness 
Later indicators include: 
• impaired ability to make friends with peers 
• impaired ability to initiate or sustain a conversation with others 
• absence or impairment of imaginative and social play 
• repetitive or unusual use of language 
• abnormally intense or focused interest 
• preoccupation with certain objects or subjects 
• inflexible adherence to specific routines or rituals 
Health care providers will often use a questionnaire or other screening instrument to gather information about a child’s 
development and behavior. Some screening instruments rely solely on parent observations, while others rely on a 
combination of parent and doctor observations. If screening instruments indicate the possibility of ASD, a more 
comprehensive evaluation is usually indicated. 
A comprehensive evaluation requires a multidisciplinary team, including a psychologist, neurologist, psychiatrist, 
speech therapist, and other professionals who diagnose and treat children with ASD. The team members will conduct a 
thorough neurological assessment and in-depth cognitive and language testing. Because hearing problems can cause 
behaviors that could be mistaken for ASD, children with delayed speech development should also have their hearing 
tested. 
What causes ASD? 
Scientists believe that both genetics and environment likely play a role in ASD. There is great concern that rates of 
autism have been increasing in recent decades without full explanation as to why. Researchers have identified a 
number of genes associated with the disorder. Imaging studies of people with ASD have found differences in the 
development of several regions of the brain. Studies suggest that ASD could be a result of disruptions in normal brain 
growth very early in development. These disruptions may be the result of defects in genes that control brain 
development and regulate how brain cells communicate with each other. Autism is more common in children born 
prematurely. Environmental factors may also play a role in gene function and development, but no specific 
environmental causes have yet been identified. The theory that parental practices are responsible for ASD has long 
been disproved. Multiple studies have shown that vaccination to prevent childhood infectious diseases does not 
increase the risk of autism in the population. 
What role do genes play? 
Twin and family studies strongly suggest that some people have a genetic predisposition to autism. Identical twin 
studies show that if one twin is affected, then the other will be affected between 36 to 95 percent of the time. There are 
a number of studies in progress to determine the specific genetic factors associated with the development of ASD. In 
families with one child with ASD, the risk of having a second child with the disorder also increases. Many of the genes 
found to be associated with autism are involved in the function of the chemical connections between brain neurons 
(synapses). Researchers are looking for clues about which genes contribute to increased susceptibility. In some cases, 
parents and other relatives of a child with ASD show mild impairments in social communication skills or engage in 
repetitive behaviors. Evidence also suggests that emotional disorders such as bipolar disorder and schizophrenia occur 
more frequently than average in the families of people with ASD. 
In addition to genetic variations that are inherited and are present in nearly all of a person’s cells, recent research has 
also shown that de novo, or spontaneous, gene mutations can influence the risk of developing autism spectrum 
disorder.  De novo mutations are changes in sequences of deoxyribonucleic acid or DNA, the hereditary material in 
humans, which can occur spontaneously in a parent’s sperm or egg cell or during fertilization. The mutation then 
occurs in each cell as the fertilized egg divides. These mutations may affect single genes or they may be changes called 
copy number variations, in which stretches of DNA containing multiple genes are deleted or duplicated.  Recent 
studies have shown that people with ASD tend to have more copy number de novo gene mutations than those without 
the disorder, suggesting that for some the risk of developing ASD is not the result of mutations in individual genes but 
rather spontaneous coding mutations across many genes.  De novo mutations may explain genetic disorders in which 
an affected child has the mutation in each cell but the parents do not and there is no family pattern to the disorder. 
Autism risk also increases in children born to older parents. There is still much research to be done to determine the 
potential role of environmental factors on spontaneous mutations and how that influences ASD risk. 
Do symptoms of autism change over time? 
For many children, symptoms improve with age and behavioral treatment. During adolescence, some children with 
ASD may become depressed or experience behavioral problems, and their treatment may need some modification as 
they transition to adulthood. People with ASD usually continue to need services and supports as they get older, but 
depending on severity of the disorder, people with ASD may be able to work successfully and live independently or 
within a supportive environment. 
How is autism treated? 
There is no cure for ASD. Therapies and behavioral interventions are designed to remedy specific symptoms and can 
substantially improve those symptoms. The ideal treatment plan coordinates therapies and interventions that meet the 
specific needs of the individual. Most health care professionals agree that the earlier the intervention, the better. 
Educational/behavioral interventions: Early behavioral/educational interventions have been very successful in many 
children with ASD. In these interventions therapists use highly structured and intensive skill-oriented training sessions 
to help children develop social and language skills, such as applied behavioral analysis, which encourages positive 
behaviors and discourages negative ones. In addition, family counseling for the parents and siblings of children with 
ASD often helps families cope with the particular challenges of living with a child with ASD. 
  
Medications: While medication can’t cure ASD or even treat its main symptoms, there are some that can help with 
related symptoms such as anxiety, depression, and obsessive-compulsive disorder. Antipsychotic medications are used 
to treat severe behavioral problems. Seizures can be treated with one or more anticonvulsant drugs. Medication used to 
treat people with attention deficit disorder can be used effectively to help decrease impulsivity and hyperactivity in 
people with ASD. Parents, caregivers, and people with autism should use caution before adopting any unproven 
treatments. 
What research is being done? 
The mission of the National Institute of Neurological Disorders and Stroke (NINDS) is to seek fundamental 
knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease. 
The NINDS is a component of the National Institutes of Health (NIH), the leading supporter of biomedical research in 
the world.  NINDS and several other NIH Institutes and Centers support research on autism spectrum disorder.  
Nearly 20 years ago the NIH formed the Autism Coordinating Committee (NIH/ACC) to enhance the quality, pace, 
and coordination of efforts at the NIH to find a cure for autism 
(http://www.nids.nih.gov/autism_coordinating_committee). The NIH/ACC has been instrumental in promoting 
research to understand and advance ASD. The NIH/ACC also participates in the broader Federal Interagency Autism 
Coordinating Committee (IACC), composed of representatives from various U.S. Department of Health and Human 
Services agencies, the Department of Education, and other governmental organizations, as well as public members, 
including individuals with ASD and representatives of patient advocacy organizations. One responsibility of the IACC 
is to develop a strategic plan for ASD research, which guides research programs supported by NIH and other 
participating organizations. 
NINDS and several other NIH institutes support autism research through the Autism Centers of Excellence (ACE), a 
trans-NIH initiative that supports large-scale multidisciplinary studies on ASD, with the goal of determining the causes 
of autism and finding new treatments. NINDS currently supports an ACE network focused on ASD and tuberous 
sclerosis complex (TSC). ASD occurs in approximately half of TSC patients. In particular, the ACE investigators are 
studying whether certain brain imaging and activity measures in infants diagnosed with TSC can predict the 
development of ASD. Such biomarkers could aid in understanding how and why ASD occurs in some children but not 
others, and help to identify patients who might benefit from early intervention. Other ACE centers and networks are 
investigating early brain development and functioning; genetic and non-genetic risk factors, including neurological, 
physical, behavioral, and environmental factors present in the prenatal period and early infancy; and potential 
therapies. 
NINDS funds additional research aimed at better understanding the factors that lead to ASD, including other studies on 
genetic disorders associated with ASD, such as TSC, Fragile X Syndrome, Phelan-McDermid syndrome (which 
features such autism-like symptoms as intellectual disability, developmental delays, and problems with developing 
functional language), and Rett syndrome (a disorder that almost exclusively affects girls and is characterized by 
slowing development, intellectual disability, and loss of functional use of the hands). Many of these studies use animal 
models to determine how specific known mutations affect cellular and developmental processes in the brain, yielding 
insights relevant to understanding ASD due to other causes and discovering new targets for treatments. 
NINDS researchers are studying aspects of brain function and development that are altered in people with ASD. For 
example, NINDS-funded researchers are investigating the formation and function of neuronal synapses, the sites of 
communication between neurons, which may not properly operate in ASD and neurodevelopmental disorders. Other 
studies use brain imaging in people with and without ASD to identify differences in brain connectivity and activity 
patterns associated with features of ASD. Researchers hope that understanding these alterations can help identify new 
opportunities for therapeutic interventions. Additional NINDS researchers are studying the relationship between 
epilepsy and autism. 
Through the National Center for Advancing Translational Sciences (NCATS) Rare Disease Clinical Research 
Network (RDCRN), NINDS and other NIH Institutes and Centers support a research consortium focused on three rare 
genetic syndromes associated with ASD and intellectual disability, including TSC and syndromes involving mutations 
in the genes SHANK3 (Phelan-McDermid syndrome) and PTEN. The goals of the consortium are to understand shared 
mechanisms across these syndromes, which may suggest common approaches to their treatment. 
NINDS supports autism spectrum disorder research through clinical trials at medical centers across the United States 
to better our knowledge about ASD treatment and care. Information about participating in clinical studies can be found 
at the “NIH Clinical Trials and You” website at www.nih.gov/health/clinicaltrials. Additional studies can be found at 
www.clinicaltrials.gov. People should talk to their doctor before enrolling in a clinical trial. 
More information about research on ASD supported by NINDS and other NIH Institutes and Centers can be found 
using NIH RePORTER (projectreporter.nih.gov), a searchable database of current and past research projects 
supported by NIH and other federal agencies. RePORTER also includes links to publications and resources from these 
projects. 
Where can I get more information? 
For more information on neurological disorders or research programs funded by the National Institute of Neurological 
Disorders and Stroke, contact the Institute's Brain Resources and Information Network (BRAIN) at:  
BRAIN 
P.O. Box 5801 
Bethesda, MD 20824 
800-352-9424 
http://www.ninds.nih.gov  
Information also is available from the following organizations: 
  
Centers for Disease Control and 
Prevention (CDC) 
U.S. Department of Health and Human 
Services 
1600 Clifton Road 
Atlanta, GA 30333 
inquiry@cdc.gov 
http://www.cdc.gov  
Tel: 800-311-3435 404-639-3311/404-639-
3543 
National Institute of Child Health and 
Human Development (NICHD) 
National Institutes of Health, DHHS 
31 Center Drive, Rm. 2A32 MSC 2425 
Bethesda, MD 20892-2425 
http://www.nichd.nih.gov  
Tel: 301-496-5133 
Fax: 301-496-7101 
National Institute on Deafness and Other 
Communication Disorders (NIDCD) 
National Institutes of Health, DHHS 
31 Center Drive, MSC 2320 
Bethesda, MD 20892-2320 
nidcdinfo@nidcd.nih.gov 
http://www.nidcd.nih.gov  
Tel: 301-496-7243/800-241-1044 800-241-
1055 (TTD/TTY) 
National Institute of Environmental Health 
Sciences (NIEHS) 
National Institutes of Health, DHHS 
111 T.W. Alexander Drive 
Research Triangle Park, NC 27709 
webcenter@niehs.nih.gov 
http://www.niehs.nih.gov  
Tel: 919-541-3345 
National Institute of Mental Health 
(NIMH) 
National Institutes of Health, DHHS 
6001 Executive Blvd. Rm. 8184, MSC 9663 
Bethesda, MD 20892-9663 
nimhinfo@nih.gov 
http://www.nimh.nih.gov  
Tel: 301-443-4513/866-415-8051 301-443-
8431 (TTY) 
Fax: 301-443-4279 
Association for Science in Autism 
Treatment 
P.O. Box 1447 
Hoboken, NJ 07030 
info@asatonline.org 
http://www.asatonline.org  
Autism National Committee (AUTCOM) 
P.O. Box 429 
Forest Knolls, CA 94933 
Autism Network International (ANI) 
P.O. Box 35448 
Syracuse, NY 13235-5448 
jisincla@syr.edu 
http://www.autcom.org  http://www.ani.ac  
Autism Research Institute (ARI) 
4182 Adams Avenue 
San Diego, CA 92116 
director@autism.com 
http://www.autismresearchinstitute.com  
Tel: 619-281-7165 866-366-3361 
Fax: 619-563-6840 
Autism Science Foundation 
28 West 39th Street 
Suite 502 
New York, NY 10018 
contactus@autismsciencefoundation.org 
http://www.autismsciencefoundation.org/  
Tel: 212-391-3913 
Fax: 212-228-3557 
Autism Society of America 
4340 East-West Highway 
Suite 350 
Bethesda, MD 20814 
http://www.autism-society.org  
Tel: 301-657-0881 800-3AUTISM (328-
8476) 
Fax: 301-657-0869 
Autism Speaks, Inc. 
1 East 33rd Street 
4th Floor 
New York, NY 10016 
contactus@autismspeaks.org 
http://www.autismspeaks.org  
Tel: 212-252-8584 (888) 288-4762 
Fax: 212-252-8676 
MAAP Services for Autism, Asperger 
Syndrome, and PDD 
P.O. Box 524 
Crown Point, IN 46308 
info@aspergersyndrome.org 
http://www.aspergersyndrome.org/  
Tel: 219-662-1311 
Fax: 219-662-1315 
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